Encouraging early results from a SAHMRI-led clinical trial offer new hope to people diagnosed with chronic myelomonocytic leukemia (CMML), a rare and aggressive form of blood cancer.CMML is notoriously difficult to treat, with limited options and a low survival rate. Current therapies often lead to only short-term responses in a small number of patients.The PREACH-M […]
